Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion type Assertion NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_head.
- NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion description "[Although ERRalpha signaling in breast cancer cells is mostly independent of ERalpha, the small fraction of common ERRalpha/ERalpha targets comprises genes with high relevance to breast tumor biology, including genes located within the ERBB2 amplicon and GATA3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_provenance.
- NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion evidence source_evidence_literature NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_provenance.
- NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion SIO_000772 19622763 NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_provenance.
- NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion wasDerivedFrom befree-20140225 NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_provenance.
- NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_assertion wasGeneratedBy ECO_0000203 NP251177.RAnhsi5qtwh4Vqfh2OlBmKUzE4Gc3rG5mx8VEL_F91FR4130_provenance.